Literature DB >> 15316343

Repeated measures study of human herpesvirus 8 (HHV-8) DNA and antibodies in men seropositive for both HHV-8 and HIV.

A Scott Laney1, Sheila C Dollard, Harold W Jaffe, Margaret K Offermann, Thomas J Spira, Clifford J Gunthel, Philip E Pellett, Michael J Cannon.   

Abstract

OBJECTIVE: To study the natural history and pathogenesis of human herpesvirus 8 (HHV-8) infection in HHV-8-seropositive, immunosuppressed men.
DESIGN: Longitudinal study of 87 HHV-8- and HIV-seropositive men [42 with Kaposi's sarcoma (KS)] during four visits over a 2 month period.
METHODS: : Patients provided oral fluid and blood. HHV-8 antibody titers were measured with peptide-based enzyme-linked immunosorbent assays (ELISA) for ORF65 and K8.1; HHV-8 DNA was detected with polymerase chain reaction ELISA.
RESULTS: HHV-8 DNA was present in oral fluid or peripheral blood mononuclear cells (PBMC) at one or more of the four visits in 71% of men with KS and 56% of men without KS. The strongest correlate of HHV-8 DNA in PBMC was the presence of KS [odds ratio (OR), 8.7; 95% confidence interval (CI), 3.4-22]. Detection of HHV-8 DNA in oral fluid or PBMC was often intermittent, but individuals who shed virus at one time point were more likely to shed at other times. Some men had incomplete epitope recognition in their anti-HHV-8 antibody response. High antibody titers were associated with the absence of circulating HHV-8, particularly for the ORF65 seroassay (OR, 0.16; 95% CI, 0.05-0.51).
CONCLUSIONS: Among HHV-8 seropositive men, circulating virus is common even in the absence of disease. The link between KS and HHV-8 DNA in PBMC suggests that anti-herpes drugs may impede KS development or progression. Seroassays should target multiple epitopes to achieve maximal sensitivity. HHV-8 replication may be limited by high antibody titers or other immune function for which antibodies are a marker.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316343     DOI: 10.1097/00002030-200409030-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.

Authors:  Roberto Flores; James J Goedert
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

Review 2.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

3.  Donor-derived Kaposi's sarcoma in a liver-kidney transplant recipient.

Authors:  S C Dollard; D Douglas; S V Basavaraju; D S Schmid; M Kuehnert; B Aqel
Journal:  Am J Transplant       Date:  2017-10-25       Impact factor: 8.086

4.  Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  A Scott Laney; Jonathan S Peters; Susan M Manzi; Lawrence A Kingsley; Yuan Chang; Patrick S Moore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus.

Authors:  Lisa K Poppe; Chipepo Kankasa; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

6.  Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection.

Authors:  Elisa Martró; Michael J Cannon; Sheila C Dollard; Thomas J Spira; A Scott Laney; Chin-Yih Ou; Philip E Pellett
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 7.  New approaches to the treatment of human herpesvirus 8-associated disease.

Authors:  Corey Casper
Journal:  Rev Med Virol       Date:  2008 Sep-Oct       Impact factor: 6.989

8.  Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies.

Authors:  Veenu Minhas; Lynsey N Crosby; Kay L Crabtree; Saul Phiri; Tendai J M'soka; Chipepo Kankasa; William J Harrington; Charles D Mitchell; Charles Wood
Journal:  Clin Vaccine Immunol       Date:  2008-05-28

9.  LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

Authors:  E Long; M Ilie; V Hofman; K Havet; E Selva; C Butori; J P Lacour; A M Nelson; G Cathomas; P Hofman
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

10.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.

Authors:  Warren Phipps; Fred Ssewankambo; Huong Nguyen; Misty Saracino; Anna Wald; Lawrence Corey; Jackson Orem; Andrew Kambugu; Corey Casper
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.